Ozempic vs. Amaryl
See how Ozempic and Amaryl compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ozempic and Amaryl both lower blood sugar in type 2 diabetes, but only Ozempic has FDA approval for cardiovascular and kidney protection in at-risk patients.
Ozempic is a once-weekly injection with a higher list price, while Amaryl is a once-daily oral tablet available as a low-cost generic.
Amaryl carries a real risk of hypoglycemia, while Ozempic's most common side effects are gastrointestinal, like nausea and vomiting.
Ozempic vs. Amaryl Drug Summary
Ozempic
Ozempic is a GLP-1 receptor agonist that lowers blood sugar in adults with type 2 diabetes. It also reduces the risk of heart attack, stroke, and cardiovascular death in patients with existing heart disease, and slows kidney damage progression. It is given as a once-weekly injection under the skin.
Amaryl
Amaryl is a sulfonylurea that lowers blood sugar in adults with type 2 diabetes by helping the pancreas release more insulin. It is taken as a once-daily oral tablet, alongside diet and exercise. It has been used for decades and is available as a low-cost generic.
Ozempic vs. Amaryl Side Effects
Ozempic
Amaryl
Ozempic vs. Amaryl Dosage
Ozempic
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 0.5 mg once weekly | Week 5 onward |
| Dose changes | 1 increase | Every 4 weeks |
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg once daily | At the start |
| Maximum dose | 8 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Ozempic
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 0.5 mg once weekly | Week 5 onward |
| Dose changes | 1 increase | Every 4 weeks |
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg once daily | At the start |
| Maximum dose | 8 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Ozempic vs. Amaryl Indications
Ozempic
Ozempic is FDA-approved to improve blood sugar control in type 2 diabetes when combined with diet and exercise. It also carries specific approvals to reduce major cardiovascular events in patients with known heart disease and to slow chronic kidney disease progression. These added indications make it a common choice for diabetics with cardiovascular or kidney risk factors.
Blood sugar control in type 2 diabetes with diet and exercise
Reduces risk of heart attack, stroke, and cardiovascular death in patients with heart disease
Slows kidney damage progression in chronic kidney disease
Not approved for weight loss (that indication belongs to Wegovy)
Amaryl
Amaryl is FDA-approved as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It does not carry approvals for cardiovascular or kidney protection like some newer diabetes drugs. It is often used as a first-line or add-on oral option, including in combination with insulin.
Blood sugar control in type 2 diabetes with diet and exercise
Can be added to insulin therapy if sulfonylurea alone is not enough
Only sulfonylurea FDA-approved for combination therapy with insulin
Not approved for cardiovascular or kidney protection
Ozempic vs. Amaryl Pros and Cons
Ozempic
Ozempic offers benefits beyond blood sugar control, including proven cardiovascular and kidney protection in at-risk patients. It requires only one injection per week, but it carries a boxed warning for thyroid tumors seen in animal studies and costs more without insurance.
Pros
Reduces cardiovascular risk in patients with heart disease
Slows chronic kidney disease progression
Once-weekly injection, no daily pills
Often causes weight loss as a side benefit
Cons
Requires injection, not a pill
Common GI side effects like nausea and vomiting
Boxed warning for thyroid C-cell tumors
Roughly $935 to $1,043 per month without insurance, before savings programs
Amaryl
Amaryl works differently, stimulating the pancreas to release more insulin, and it comes as a once-daily tablet. It has been available for decades as a low-cost generic, but it carries a higher risk of hypoglycemia than newer options like Ozempic. It also lacks any proven cardiovascular or kidney benefit.
Pros
Once-daily oral tablet, no injections
Roughly $15 to $110 per month without insurance, before savings programs
Decades of clinical use and established safety profile
Can be combined with insulin for added control
Cons
Higher risk of hypoglycemia, especially with missed meals
Possible increased cardiovascular mortality risk noted in older studies
No proven cardiovascular or kidney protective benefit
Requires careful dosing to avoid dizziness or accidental injury
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.